N. Siliprandi

3.4k total citations
135 papers, 2.7k citations indexed

About

N. Siliprandi is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, N. Siliprandi has authored 135 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 60 papers in Clinical Biochemistry and 42 papers in Physiology. Recurrent topics in N. Siliprandi's work include Metabolism and Genetic Disorders (60 papers), Mitochondrial Function and Pathology (50 papers) and Adipose Tissue and Metabolism (21 papers). N. Siliprandi is often cited by papers focused on Metabolism and Genetic Disorders (60 papers), Mitochondrial Function and Pathology (50 papers) and Adipose Tissue and Metabolism (21 papers). N. Siliprandi collaborates with scholars based in Italy, United States and United Kingdom. N. Siliprandi's co-authors include D. Siliprandi, Antonio Toninello, Fabio Di Lisa, M. Ciman, Lucia Cavallini, L. Sartorelli, Alberto Bindoli, Roberta Menabò, Franco Zoccarato and Giovanni Miotto and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

N. Siliprandi

133 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Siliprandi Italy 29 1.5k 890 657 435 353 135 2.7k
H. S. A. Sherratt United Kingdom 34 1.9k 1.2× 1.4k 1.6× 738 1.1× 300 0.7× 274 0.8× 114 3.0k
S.V. Pande Canada 23 1.6k 1.1× 1.2k 1.4× 554 0.8× 248 0.6× 290 0.8× 37 2.3k
Donald A. Vessey United States 33 1.9k 1.2× 402 0.5× 359 0.5× 462 1.1× 330 0.9× 113 3.1k
W. C. McMurray Canada 21 1.5k 1.0× 504 0.6× 428 0.7× 234 0.5× 519 1.5× 60 2.4k
Joan A. Manning United States 19 1.8k 1.2× 521 0.6× 421 0.6× 196 0.5× 428 1.2× 24 2.7k
B. Shapiro Israel 28 1.4k 0.9× 415 0.5× 924 1.4× 464 1.1× 753 2.1× 66 2.9k
Maurice Wibo Belgium 27 2.3k 1.5× 325 0.4× 654 1.0× 670 1.5× 348 1.0× 67 3.9k
Kou‐Yi Tserng United States 27 1.1k 0.7× 329 0.4× 521 0.8× 293 0.7× 153 0.4× 74 2.4k
J. D. Judah United Kingdom 35 1.6k 1.0× 291 0.3× 362 0.6× 449 1.0× 221 0.6× 81 3.0k
Paul E. Minkler United States 32 1.9k 1.2× 897 1.0× 801 1.2× 172 0.4× 326 0.9× 61 2.8k

Countries citing papers authored by N. Siliprandi

Since Specialization
Citations

This map shows the geographic impact of N. Siliprandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Siliprandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Siliprandi more than expected).

Fields of papers citing papers by N. Siliprandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Siliprandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Siliprandi. The network helps show where N. Siliprandi may publish in the future.

Co-authorship network of co-authors of N. Siliprandi

This figure shows the co-authorship network connecting the top 25 collaborators of N. Siliprandi. A scholar is included among the top collaborators of N. Siliprandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Siliprandi. N. Siliprandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salamino, F., Fabio Di Lisa, Alberto Burlina, et al.. (1994). Involvement of Erythrocyte Calpain in Glycine-and Carnitine-Treated Isovaleric Acidemia. Pediatric Research. 36(2). 182–186. 3 indexed citations
2.
Bordin, Luciana, et al.. (1994). Spermine-mediated casein kinase II-uptake by rat liver mitochondria. Biochimica et Biophysica Acta (BBA) - General Subjects. 1199(3). 266–270. 13 indexed citations
3.
Siliprandi, D., et al.. (1992). Effects of palmitoyl CoA and palmitoyl carnitine on the membrane potential and Mg2+ content of rat heart mitochondria. PubMed. 116(1-2). 117–123. 19 indexed citations
4.
Siliprandi, N., Fabio Di Lisa, & Roberta Menabò. (1991). Propionyl-L-carnitine: Biochemical significance and possible role in cardiac metabolism. Cardiovascular Drugs and Therapy. 5(1). 11–15. 58 indexed citations
5.
Pontremoli, S., E. Melloni, P.L. Viotti, et al.. (1990). Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms. Biochemical and Biophysical Research Communications. 167(1). 373–380. 31 indexed citations
6.
Siliprandi, N., Fabio Di Lisa, Patrizio Ripari, et al.. (1990). Metabolic changes induced by maximal exercise in human subjects following L-carnitine administration. Biochimica et Biophysica Acta (BBA) - General Subjects. 1034(1). 17–21. 58 indexed citations
7.
Vecchiet, L, Fabio Di Lisa, Patrizio Ripari, et al.. (1990). Influence of L-carnitine administration on maximal physical exercise. European Journal of Applied Physiology. 61(5-6). 486–490. 72 indexed citations
8.
Siliprandi, N., L. Sartorelli, M. Ciman, & Fabio Di Lisa. (1989). Carnitine: Metabolism and clinical chemistry. Clinica Chimica Acta. 183(1). 3–11. 76 indexed citations
9.
Lisa, Fabio Di, et al.. (1989). Ca2+-mediated action of long-chain acyl-CoA on liver mitochondria energy-linked processes. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 973(2). 185–188. 10 indexed citations
10.
Branca, Donata, et al.. (1988). Evaluation of some mitochondrial functions following liver perfusion with perfluorotributylamine emulsions. Biochemical Pharmacology. 37(12). 2479–2481. 5 indexed citations
11.
Toninello, Antonio, et al.. (1988). Bidirectional Transport of Spermine Across the Inner Membrane of Liver Mitochondria. Advances in experimental medicine and biology. 250. 491–496. 4 indexed citations
12.
Toninello, Antonio, et al.. (1988). Protective action of methylglyoxal bis (guanylhydrazone) on the mitochondrial membrane. Biochemical Pharmacology. 37(18). 3395–3399. 9 indexed citations
13.
Siliprandi, N., et al.. (1988). Effect of L‐Carnitine on Ethanol and Acetate Plasma Levels after Oral Administration of Ethanol in Humans. Alcoholism Clinical and Experimental Research. 12(5). 653–654. 10 indexed citations
14.
Siliprandi, N., M. Ciman, & L. Sartorelli. (1987). Myocardial carnitine transport. Steinkopff eBooks. 82 Suppl 1. 53–62. 16 indexed citations
15.
Cavallini, Lucia, Alberto Bindoli, & N. Siliprandi. (1978). Comparative evaluation of antiperoxidative action of silymarin and other flavonoids. Pharmacological Research Communications. 10(2). 133–143. 75 indexed citations
16.
Branca, Donata, Guido Scutari, & N. Siliprandi. (1978). Diamide effect on the hypertonic calcium uptake by rat red blood cells. Journal of Cellular Physiology. 95(3). 319–322. 5 indexed citations
17.
Branca, Donata, Guido Scutari, & N. Siliprandi. (1977). Carnitine effect on heart steatosis induced in rats by rapeseed oil.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 47(2). 162–6. 4 indexed citations
18.
Baglioni, Corrado, P. Fasella, C Turano, & N. Siliprandi. (1960). Metabolism of xanthurenic acid in the rat. Biochemical Journal. 74(3). 521–525. 5 indexed citations
19.
Cerletti, Paolo, et al.. (1957). Ion-exchange resins in single columns and coupled columns. Separation of some amino acids and of riboflavin phosphates.. 41. 554–558. 2 indexed citations
20.
Navazio, F, N. Siliprandi, & A. Rossi‐Fanelli. (1956). Pure crystalline oxythiamine phosphoric esters preparation and some chemical and biological properties. Biochimica et Biophysica Acta. 19(2). 274–279. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026